Image Rotator

Researchers to study the impact of adipose stem cell therapy on healing small and partial thickness rotator cuff tears.
Stem cell therapy trial at Sanford first of its kind in U.S. for shoulder injuries
Researchers to study the impact of adipose stem cell therapy on healing small and partial thickness rotator cuff tears.

There are currently no Featured Stories.


Sanford Research is a non-profit research organization that is a part of Sanford Health, the largest rural, not-for-profit health care system in the nation. Transformational gifts by Denny Sanford have propelled Sanford Research in its goal of becoming a world class research institution. Sanford Research has sought to establish a core of scientists that are studying disease at a fundamental level with the expectation that these current efforts will pay off in the future by advancing disease therapy and prevention.

 

With a team of over 200 researchers, Sanford Research is comprised of eight groups that bridge bench, translational and clinical research including: Cancer Biology and Immunotherapies, Pediatrics and Rare Diseases, Diabetes, Cellular Therapies and Stem Cell Biology, Enabling Technology, Environmental Influences on Health and Disease, Genetics and Genomics, and Population Health.

  • Oncology group chooses Sanford for first clinical trial

    Sanford launches national TAPUR Study for patients with advanced cancer. The clinical study offers FDA-approved, molecularly targeted drugs to participants.

    Learn More

  • Sanford launches innovative data project to improve patient care

    Dakota universities part of effort

    Learn More

  • New clinical trial launches at Sanford

    Head and neck cancer patients could benefit from new checkpoint inhibitor treatment at Sanford.

    Learn More

  • Sanford Enrolling Patients for Head, Neck Cancer Trial

    Studying investigational drug to determine if it helps activate immune system

    Learn More

Twitter Updates on Sanford Research
  • @DrDavidPearce
    RT @NatureRevGenet: Dissecting evolution and disease using comparative vertebrate genomics https://t.co/mzfGgTamTW #review https://t.co/ZWy…

  • @Karen889510
    RT @Rose_of_Sharon8: Annual Klippel-Feil Syndrome #KFStroll walk Patients Family Friends Family meet GLOBAL > https://t.co/m63qVWoaAu @Glob…

  • @SanfordCoRDS
    RT @Rose_of_Sharon8: Annual Klippel-Feil Syndrome #KFStroll walk Patients Family Friends Family meet GLOBAL > https://t.co/m63qVWoaAu @Glob…

  • @GlobalGenes
    RT @Rose_of_Sharon8: Annual Klippel-Feil Syndrome #KFStroll walk Patients Family Friends Family meet GLOBAL > https://t.co/m63qVWoaAu @Glob…

  • @Rose_of_Sharon8
    Annual Klippel-Feil Syndrome #KFStroll walk Patients Family Friends Family meet GLOBAL > https://t.co/m63qVWoaAu… https://t.co/urpWBDfMoh

  • @DrDavidPearce
    RT @NatureGenet: Rare coding variants implicate microglial-mediated innate immunity in Alzheimer's disease (Sims et al.) https://t.co/n6vx6…

  • @DrDavidPearce
    RT @sciencemagazine: This weekend's a great time to get ready to #DanceYourPhD. Join the contest by September 29: https://t.co/e5EfE3aA53 h…

  • @DrDavidPearce
    RT @DrAllisonW: A decade on, vaccine has halved cervical cancer rate https://t.co/KdEfTMmGYj

  • @DrDavidPearce
    Changes in #DNA methylation may provide a signature risk for #BreastCancer https://t.co/aUiHGcIF9Y #Epigenetics

  • @DrDavidPearce
    A better understanding of #Radiation therapy will lead to better outcomes in #Cancer https://t.co/BXnD1W68lq

  • @DrDavidPearce
    #Biomarker for #Epilepsy could lead to targeted treatment of #Seizures https://t.co/wd8UAKeVWL #RareDiseases #Neuroscience

  • @DrDavidPearce
    RT @eurordis: 12th Annual International Conference on #Rarediseases and #OrphanDrugs will be held in China, September 7-10 https://t.co/W6b…

  • @SanfordCoRDS
    RT @SGottliebFDA: In June FDA launch plan to eliminate 200 application orphan drug designation backlog. Our great team is 60% to goal https…

  • @DrDavidPearce
    RT @SGottliebFDA: In June FDA launch plan to eliminate 200 application orphan drug designation backlog. Our great team is 60% to goal https…

  • @DrDavidPearce
    High Intensity Sequencing of circulating #DNA improves #Cancer patients chance of treatment https://t.co/9JEpm7FIQ6 #BigData